EDTA Chelation Therapy, Heart Disease And Chronic Disease
Chronic degenerative disease flood the American healthcare system with sufferers. In spite of modern medicine’s ability to reduce symptoms of many illnesses, their fundamental causes-and cures – still elude traditional practitioners. Because toxic heavy metals are associated with our two biggest challenges, cancer and heart disease (as well as many other severe disease states), the etiology of heavy metal toxicity must be recognized and addressed. EDTA Chelation is the answer. A therapy whose time has come, chelation should now defined and understood as a 21st century modality of choice for removing toxic metals from the body.
The Amazing Benefits of EDTA Chelation Therapy
For over 50 years EDTA chelation therapy has improved blood flow and benefited every cell in the body. It now serves as a highly effective and safe treatment (intravenous or Detoxamin suppository) for the elimination of toxic heavy metals and improvement of circulation and health. EDTA Chelation Therapy is used worldwide for arteriosclerosis, heavy metal toxicity, memory problems, heart disease, fatigue, circulation problems and more. It has helped restore healthy function and quality of life to our patients, many of whom have been able to prevent the need for painful and costly surgeries or to rely on prescription medications.
- Atherosclerosis is the main cause for heart attack and strokes.
The endothelium is inner lining of blood vessels.
This lining tissue generates the powerful arterial vessel dilator nitric oxide (N.O.).
The endothelium also produces prostacyclin which slows the clotting of blood and also causes beneficial dilating of arteries.
The third important endothelial product is heparin which prevents clots from forming without causing bleeding.
Excessive deposition of heavy metals in the endothelium diminishes the endothelium’s ability to produce nitric oxide, prostacyclin, and heparin. *Iron and the sex differences in heart disease risk.(Lancet, 1981 June 13; 1(8233):1293-1294)
N.O. is a potent vasodilator and a strong antioxidant.
When the endothelium is damaged, N.O. production is reduced.
When the endothelium is damaged, N.O. production is reduced.
The endothelium also produces prostacyclin which slows the clotting of blood and also causes beneficial dilating of arteries.
Removal of these metals appears to result in improved delivery of oxygen and nutrients to the tissues of the body.
It does appear however that the discovery of N.O. production increasing with EDTA chelation is exactly what is happening.
Today it is imperative for anyone with high blood pressure, heart disease, prostate issues, cardiovascular disease, chronic fatigue, or cancer, to rid the body of heavy metals with EDTA.
Toxic metals attack the endothelium
How Do Metals Produce Toxicity?
Heavy metals in general have no basic function in the body and can be highly toxic. High- concentration exposure is not necessary in order to produce a state of toxicity in the body. Most cases of heavy metal poisoning result from chronic low level exposure to these hazardous environmental toxins. In the last 50 years, human exposure to heavy metals has risen dramatically. This is the result of an exponential increase in the use of heavy metals in industrial processes and products. Today chronic exposure comes from toxic waste dump and burn sites, agriculture, chemical products, mercury amalgam dental fillings, lead-based paint, tap water, and chemical residues in processed foods. Personal care products, such as cosmetics, mouthwash, toothpaste, soap, shampoo, and other hair care goods, are also sources of contamination. In addition to the hazards at home and outdoors, many occupations are subjected to daily heavy metal exposure. More than 50 professions are exposed to mercury on a daily basis. These include physicians, pharmaceutical workers, dentists, dental workers, laboratory workers, hairdressers, painters, printers, welders, metalworkers, cosmetic workers, battery makers, engravers, photographers, visual artists and potters.
EDTA Suppositories – IV Chelation Therapy
Chelation therapy is an intravenous or Detoxamin suppository therapy using the synthetic amino acid “EDTA” (ethylene diamine tetra-acetic acid) to detoxify the body by bonding with the toxic metals in the body and carrying them away in the urine. EDTA has the ability to bond or “hook onto” atoms of calcium, lead, cadmium, mercury, and others as well as some of the trace minerals through the process of chelation. For more than 40 years, chelation has been used successfully for patients with vascular diseases such as atherosclerosis as well as heavy metal poisoning. The FDA has approved chelation as the only treatment for lead poisoning. Improving circulation by the removal of accumulated build up (plaques) that damage the vascular system throughout the body is a primary benefit for patients with heart disease (atherosclerosis), diabetes and other circulatory diseases. During and following chelation therapy, the blood flow from arteries all the way to the smallest capillaries is improved throughout the body. Chelation has FDA approval for lead toxicity and removal.
Chelation and Cellular Oxidative Damage
Learn More About EDTA Chelation Therapy
People worldwide are concerned with aging and longevity due to the increasing of
degenerative diseases that we’re all facing today.